Does SOTORASIB Cause Off label use? 193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Off label use have been filed in association with SOTORASIB (LUMAKRAS). This represents 6.6% of all adverse event reports for SOTORASIB.
193
Reports of Off label use with SOTORASIB
6.6%
of all SOTORASIB reports
41
Deaths
22
Hospitalizations
How Dangerous Is Off label use From SOTORASIB?
Of the 193 reports, 41 (21.2%) resulted in death, 22 (11.4%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTORASIB. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does SOTORASIB Cause?
Non-small cell lung cancer (483)
Death (319)
Disease progression (314)
Diarrhoea (284)
Nausea (98)
Non-small cell lung cancer metastatic (93)
Hepatotoxicity (91)
Fatigue (87)
Hepatic function abnormal (80)
Aspartate aminotransferase increased (71)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SOTORASIB Alternatives Have Lower Off label use Risk?
SOTORASIB vs SOTROVIMAB
SOTORASIB vs SOVALDI
SOTORASIB vs SOYBEAN OIL
SOTORASIB vs SPARSENTAN
SOTORASIB vs SPARTALIZUMAB